Stock Market Reviews

Read and share opinions on CRBP (Corbus Pharmaceuticals Holdings, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the

Latest News

• Corbus Pharmaceuticals: Q3 Earnings Snapshot
  Nov 12, 2025
• Corbus Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
  Nov 12, 2025
• Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences
  Nov 6, 2025
• Corbus Pharmaceuticals Announces Pricing of Public Offering
  Oct 31, 2025
• Corbus Pharmaceuticals Announces Proposed Public Offering
  Oct 30, 2025
• Corbus Pharmaceuticals Presents CRB-701 Robust Clinical Responses in HNSCC and Cervical Cancers at ESMO25
  Oct 18, 2025
• Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025
  Oct 14, 2025
• Corbus Pharmaceuticals to Participate in the Upcoming Piper Sandler Virtual Oncology Symposium
  Oct 7, 2025
• Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ESMO 2025
  Sep 22, 2025
• FDA Grants Fast Track Designation to Corbus Pharmaceuticals’ Nectin-4 Targeting ADC CRB-701 in Head and Neck Squamous Cell Carcinoma
  Sep 16, 2025
• Corbus Pharmaceuticals: Q2 Earnings Snapshot
  Aug 5, 2025
• Corbus Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
  Aug 5, 2025
• Corbus Pharmaceuticals Announces Upcoming Presentation of Dose Expansion Phase 1/2 Clinical Data for its Nectin-4 Targeting ADC CRB-701 at the 2025 ESMO Annual Congress
  Jul 30, 2025
• Corbus Pharmaceuticals Initiates Multiple Ascending Dose Portion of Phase 1 Study of Highly Peripherally Restricted CB1 Inverse Agonist CRB-913 for the Treatment of Obesity
  Jun 30, 2025
• Corbus Pharmaceuticals Announces First Patient Dosed with its Nectin-4 Targeting ADC CRB-701 in Combination with Pembrolizumab
  Jun 25, 2025
• Corbus Pharmaceuticals to Participate in the 3rd Annual Piper Obesity Symposium
  Jun 24, 2025
• Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
  May 22, 2025
• Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair
  May 19, 2025